FUBT
CRSP icon

First United Bank & Trust’s CRISPR Therapeutics CRSP Stock Holding History

First United Bank & Trust’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.36K Hold
135
– – ﹤0.01% 349
2026
Q1 		$6.42K Buy
135
+35
+35% +$1.85K ﹤0.01% 340
2025
Q4 		$5.24K Hold
100
– – ﹤0.01% 345
2025
Q3 		$6.48K Hold
100
– – ﹤0.01% 360
2025
Q2 		$4.86K Hold
100
– – ﹤0.01% 340
2025
Q1 		$3.4K Hold
100
– – ﹤0.01% 363
2024
Q4 		$3.94K Hold
100
– – ﹤0.01% 351
2024
Q3 		$4.7K Hold
100
– – ﹤0.01% 347
2024
Q2 		$5.4K Hold
100
– – ﹤0.01% 357
2024
Q1 		$6.82K Hold
100
– – ﹤0.01% 366
2023
Q4 		$6.26K Buy
+100
New +$5.53K ﹤0.01% 380

Other funds holding CRSP

EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
SC
Slow Capital Greenbrae, California $857M AUM 38.3% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return
CIC
Canal Insurance Company Greenville, South Carolina $456M AUM 40.11% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WETS
Wealth Enhancement Trust Services Sioux Falls, South Dakota $900M AUM
BIP
Bouvel Investment Partners Phoenixville, Pennsylvania $442M AUM 70.77% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

First United Bank & Trust's CRSP Position: Q2 2026 in Review

First United Bank & Trust held its CRISPR Therapeutics (CRSP) position steady in Q2 2026 at 135 shares worth $7.36K. The position accounts for ﹤0.01% of the portfolio, ranked #349.

First United Bank & Trust first reported a position in CRSP in Q4 2023 and has held it in 11 quarters since. 109 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • First United Bank & Trust held 135 shares of CRISPR Therapeutics worth $7.36K as of Q2 2026.
  • First United Bank & Trust left its CRISPR Therapeutics share count unchanged in Q2 2026.
  • CRISPR Therapeutics made up ﹤0.01% of First United Bank & Trust's portfolio in Q2 2026, its #349 holding.
  • First United Bank & Trust first reported a position in CRISPR Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 109 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on First United Bank & Trust's 13F filing for Q2 2026, filed 20 Jul 2026.